Sunday 18 April 2021
Home      All news      Contact us      RSS      India
newsonair.nic.in - 2 month ago

Covaxin demonstrates interim clinical efficacy of 81% in its phase-3 trial

Covaxin demonstrates interim clinical efficacy of 81% in its phase-3 trial


Latest News
Hashtags:   

Covaxin

 | 

demonstrates

 | 

interim

 | 

clinical

 | 

efficacy

 | 

phase

 | 

trial

 | 

Sources